- JP-listed companies
- 3-D Matrix,Ltd.
- Financials
- EBITDA margin (%)
3-D Matrix,Ltd. (7777)
Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
| Period End | EBITDA margin (%) | YoY (%) |
|---|---|---|
| Apr 30, 2016 | -1,253.2 | -32.43% |
| Apr 30, 2015 | -1,854.6 |